Morgan Stanley 13D and 13G filings for Pharming Group N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-07 4:04 pm Sale | 2025-03-31 | 13G | PHARMING GROUP N V ADR PHAR | MORGAN STANLEY MS | 8,471,801 1.200% | -35,689,678 (-80.82%) | Filing |
| 2024-11-08 3:03 pm Purchase | 2024-09-30 | 13G | PHARMING GROUP N V ADR PHAR | MORGAN STANLEY MS | 44,161,479 6.500% | 44,161,479 (New Position) | Filing |